Managing Diabetes Mellitus in Chronic Kidney Disease: Approaches
Article Sidebar
Page Numbers:
239-246
Digital Object Identifier:
10.58578/ajcmpr.v2i2.5222
Viewed: 335 times
Downloaded: 137 times
LYAS Publisher cordially invites qualified professionals to serve as Editors or Reviewers. Your expertise will make an important contribution to maintaining and strengthening the academic quality of our publications. Interested applicants are kindly requested to complete the application form at the following link: Editors & Reviewers
Please feel free to contact us if you need any further information about the submission process or if you have any additional questions.
Authors:
Muhammad Akram1, Tahmina Maqbool2, Mohammed Khudhair Hasan3, Hind A. Abdulghafoor4, Fahad Said Khan5, Gaweł Sołowski6, Isaac John Umaru7 
Copyright :
Authors retain copyright and grant the journal right of first publication.
Main Article Content
Abstract
The main objective of this article is to review the medical management of the disease known as “diabetes mellitus” and its general consequences. To assess the risks and benefits of intensive glycemic control in patients with diabetic kidney disease, the search was refined using the following specific terms: “diabetic nephropathy” and “kidney disease”, as well as “diabetes management” and “antidiabetic agents” or “oral hypoglycemic agents”. A unique challenge. Due to changes in insulin production, glucose transport and metabolism, impaired renal function is associated with hyperglycemia and hypoglycemia. Management of hyperglycemia is more difficult in patients with diabetic nephropathy, which often requires a change in the treatment regimen. When changing diabetes medications and insulin regimens, healthcare teams responsible for the care of these patients must be vigilant and organized to make such changes.
